Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9938486 | PMC |
| http://dx.doi.org/10.1016/j.htct.2022.07.006 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Digital papillary adenocarcinoma: A case report of a rare malignant tumour with recommendations on management and follow-up.
Int J Surg Case Rep
January 2025
Department of Plastic and Reconstructive Surgery, University Hospital North Durham, Durham DH1 5TW, United Kingdom. Electronic address:
Introduction: Digital papillary adenocarcinoma (DPAC) is a rare malignant tumour of the sweat glands, usually in the digits. It has a high rate of recurrence and metastasis, yet there's a lack of guidelines for its diagnosis and management. Therefore, this report aims to evaluate procedures that provide the best outcomes, which will help create a consensus for its management.
View Article and Find Full Text PDFEffects of continuous theta burst stimulation on contralateral primary motor cortex: a concurrent TMS-EEG study.
J Neurophysiol
November 2024
Academy of Medical Engineering and Translational Medicine, Tianjin University, Tianjin, People's Republic of China.
Continuous theta burst stimulation (cTBS) is a noninvasive brain stimulation technique. cTBS modulation is an effective treatment for motor dysfunction rehabilitation in post-stroke patients. However, there's currently a lack of research on the effects of cTBS stimulation on the contralesional hemisphere.
View Article and Find Full Text PDFCombination of low-dose, long-term immunoglobulin and mirtazapine is effective in progressive multifocal leukoencephalopathy caused by JC virus infection.
BMC Neurol
October 2024
Department of Neurology, The First Affiliated Hospital, Sun Yat-sen University, Guangdong Provincial Key Laboratory of Diagnosis and Treatment of Major Neurological Diseases, National Key Clinical Department and Key Discipline of Neurology, Guangzhou, China.
Article Synopsis
- Progressive multifocal leukoencephalopathy (PML) is a severe brain disease caused by the John Cunningham Virus (JCV), with no widely accepted antiviral treatment available.
- A case study reports a patient with previous immunosuppressive therapy for dermatomyositis, who was diagnosed with PML and treated with a combination of low-dose immunoglobulin and mirtazapine, leading to significant clinical improvement and a decrease in JCV levels to zero after four months.
- This findings suggest that this combined treatment approach may effectively regulate the immune response and control the progression of PML, presenting a potential new therapy option.
AI has a democracy problem. Citizens' assemblies can help.
Science
August 2024
Department of Science and Technology Studies, University College London, London, UK.
When it comes to making decisions about artificial intelligence (AI), Eric Schmidt is very clear. In 2023, the former Google CEO told NBC's Meet the Press, "there's no way a nonindustry person can understand what is possible. It's just too new, too hard, there's not the expertise.
View Article and Find Full Text PDFCardiac adverse events after Chimeric Antigen Receptor (CAR) T cell therapies: an updated systematic review and meta-analysis.
Cardiooncology
August 2024
Cardiac Primary Prevention Research Center, Cardiovascular Diseases Research Institute, Tehran University of Medical Sciences, Tehran, Iran.
Article Synopsis
- CAR T-cell therapy is an innovative treatment for certain blood cancers, but it's linked to serious cardiovascular events (CVE), including arrhythmias and heart failure.
- A systematic review analyzed 23 studies, revealing that over half of patients experienced CVEs, particularly those with severe cytokine release syndrome (CRS).
- The findings emphasize the need for close monitoring and personalized care to address potential cardiotoxic effects, while also noting that cardiac mortality rates appear to be low, indicating room for improvement in prevention strategies.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!